Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
Key Information
Due Date: October 1, 2024
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: Not Specified
Funding Type: Cooperative Agreement
Match Required: No
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
The goal is to encourage these teams to propose revisions or enhancements, previously termed as "competing revisions", to their existing research studies. Specifically, these revisions should intend to integrate novel technical approaches or tools that were developed under the NCI Innovative Molecular Analysis Technologies (IMAT) program. The purpose of integrating these advancements should be to boost the speed and progress of the initial research study.
The awards received through this particular funding opportunity aim to motivate independent verification of these emerging technologies and speed up the process of deeming them suitable for appropriate research communities in the field of cancer research. It is a part of the NCI IMAT program and as such, seeks to encourage inter-disciplinary cooperation in generating unique methods and tools to further cancer research and fast-track scientific breakthroughs.
Key Dates
Open Date: November 28, 2023
Application Due Date: October 1, 2024
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses